Clinical Trials
3 trialsNCT01208051 2021-07-15
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT01441154 2020-09-28
Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
National Institutes of Health Clinical Center (CC)
Completed
NCT01811212 2018-04-03
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
National Cancer Institute (NCI)
Phase 2 Completed